Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Phase one, roughly 2000-2012, consolidated independent PBMs into the three dominant entities
Official Regulatory Milestone for Semaglutide Nasal Spray @Shiling Pharmas semaglutide nasal spray , developed as a novel GLP-1 nasal delivery formulation , has received: Clinical trial approval implicit acceptance from Chinas CDE (Center for Drug Evaluation, NMPA) , officially posted on the CDE website
Tumor onset and growth dynamics after RETA withdrawal showed partial protection in tumor onset and persistent protection in tumor progression with significantly reduced endpoint tumor volume and weight compared to Veh
3 Cardiovascular and renal disease models Preclinical models of atherosclerosis, hypertension, heart failure, and chronic kidney disease (CKD) enable scientists to determine how GLP-1R agonists influence vascular health
Just the science that works, at a price that makes sense
US$ 28.15
US$ 21.81
US$ 22.69
US$ 27.28
